Biosensor, Immunoassay, Myoglobin
A Myoglobin Immunoassay Biosensor is an in vitro diagnostic device that uses biosensor technology combined with immunoassay methods to rapidly measure myoglobin levels in blood, used as an early cardiac biomarker following acute myocardial infarction or muscle injury. It is FDA Class 2, requiring 510(k) clearance, with product code MVE under 21 CFR 866.5680 in the Immunology specialty. The device is not an implant and is not life-sustaining.
Research product code MVE in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- MVE
- Device Class
- FDA class 2
- Regulation Number
- 866.5680
- Medical Specialty
- Immunology
- Review Panel
- IM
- Submission Type
- 1
Device Characteristics
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 1 510(k) clearance via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K981536 | QUANTECH MYOGLOBIN ASSAY | Jun 29, 1998 | Substantially Equivalent | Hellen Professional Services |
FEI Numbers
This FDA classification entry is associated with 3 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 3 registration numbers. Click on an entry to view related FDA registrations.